Investors NewsSearch: Aug 17, 2021Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company Jun 23, 2021Rafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference on June 22, 2021 Jun 21, 2021Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company Jun 14, 2021Rafael Holdings Reports Third Quarter Fiscal Year 2021 Results Jun 14, 2021Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors May 28, 2021Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 Apr 16, 2021Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 Mar 17, 2021Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results Mar 11, 2021Rafael Holdings Enhances Senior Management Team with Additions of Ameet Mallik, CEO and William Conkling, CCO Dec 22, 2020Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor Program 1 2 3 4 5 6 << < > >>
